4
Changes in Ownership
NEOGENOMICS INC Filed Acc 0001077183-19-000230
Chief Accounting Officer sold 8,000 shares at $26.37 ($210,960)
- Chief Accounting Officer acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McKenzie Kathryn B · Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-12-10 | Exercise or conversion : show line 1 in the form | +8,000 | $8.03 | $64,240 | 10,273 | D |
| 2019-12-10 | Sale : show line 2 in the form | −8,000 | $26.37 | $210,960 | 2,273 | D |
| Open-market sales · 8,000 sh · avg $26.37 · $210,960 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-12-10 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −8,000 | $8.03 | 2023-02-26 | 8,000 | 40,000 | D |
Loading xslF345X03/wf-form4_157619689019440.xml…